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The anaphase-promoting complex/cyclosome (APC/
C) and the spindle assembly checkpoint (SAC), which
inhibits the APC/C, are essential determinants of
mitotic timing and faithful division of genetic mate-
rial. Activation of the APC/C is known to depend
on two APC/C-interacting E2 ubiquitin-conjugating
enzymes—UBE2C and UBE2S. We show that APC/
C activity in human cells is tuned by the combinato-
rial use of three E2s, namely UBE2C, UBE2S, and
UBE2D. Genetic deletion of UBE2C and UBE2S,
individually or in combination, leads to discrimina-
tive reduction in APC/C function and sensitizes
cells to UBE2D depletion. Reduction of APC/C
activity results in loss of switch-like metaphase-to-
anaphase transition and, strikingly, renders cells
insensitive to chemical inhibition of MPS1 and ge-
netic ablation of MAD2, both of which are essential
for the SAC. These results provide insights into the
regulation of APC/C activity and demonstrate that
the essentiality of the SAC is imposed by the strength
of the APC/C.
INTRODUCTION
The anaphase-promoting complex/cyclosome (APC/C) is a
multi-subunit E3 ubiquitin ligase that is essential for eukaryotic
cell division (Peters, 2006; Pines, 2011; Primorac and Musac-
chio, 2013; Sivakumar and Gorbsky, 2015). In mitosis, the
APC/C promotes ubiquitylation-mediated degradation of key
mitotic regulators, such as securin and cyclin B1 (CCNB1),
which is required for metaphase-to-anaphase transition and
cell division. The APC/C employs two E2 ubiquitin-conjugating
enzymes, UBE2C (UBCH10) and UBE2S, in tandem, whereby
UBE2C initiates substrate ubiquitylation and UBE2S subse-
quently extends substrate-linked ubiquitin to exclusively
generate K11-linked polyubiquitin chains (Garnett et al., 2009;CeSummers et al., 2008; Williamson et al., 2009; Wu et al.,
2010). In vitro, the APC/C also can initiate ubiquitylation using
UBE2D (UBCH5) and subsequently extend it to polyubiquitin
chains using UBE2S (Garnett et al., 2009; Williamson et al.,
2009; Wu et al., 2010; Yu et al., 1996). However, the role of
UBE2D in APC/C activation in vivo is unclear as depletion of
UBE2D or expression of UBE2D mutants failed to reveal its
function in mitosis (Bastians et al., 1999; Jin et al., 2008; Wil-
liamson et al., 2009).
The timing of APC/C activation in mitosis is tightly controlled
by the spindle assembly checkpoint (SAC) (London and Big-
gins, 2014), which senses kinetochores that are not attached
to microtubules and generates the mitotic checkpoint complex
(MCC). The MCC inhibits APC/C activation until all chromo-
somes are properly aligned to the metaphase plate. Unat-
tached kinetochores bind to monopolar spindle 1 (MPS1)
kinase, which activates SAC signaling (Abrieu et al., 2001;
Fisk and Winey, 2001; Hiruma et al., 2015; Ji et al., 2015;
Santaguida et al., 2010). Activation of the SAC results in
a conformational change of mitotic arrest-deficient protein
2 (MAD2 or MAD2L1) that is required for the formation
of the MCC. Inactivation of the SAC in mammalian cells
invariably leads to catastrophic aneuploidy, and, conse-
quently, genetic deletions of SAC components are lethal
(Kops et al., 2005).
Despite their central functions in mitosis, the functional
redundancy of E2s in APC/C activity and the interdependence
of the APC/C and the SAC are not fully understood. Here we
used genetic approaches to delineate the function of APC/
C-associated E2s and to assess the consequences of interme-
diate APC/C activity in cells. This enabled us to discover a
UBE2C-independent role of UBE2S and to reveal a thus far
concealed function of UBE2D in mitotic APC/C activity. Unex-
pectedly, we discovered that human cells with minimal
APC/C activity, due to simultaneous deletion of UBE2C and
UBE2S, lose their dependence on the SAC. We thus demon-
strate that human cells, which normally rely on SAC activity
for survival, can be engineered to be viable without the SAC.
These results show that the essentiality of the SAC is imposed
by the strength of the APC/C E2 module, and that human cellsll Reports 14, 1829–1840, March 1, 2016 ª2016 The Authors 1829
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Figure 1. Genetic Analysis of APC/C-Asso-
ciated E2s Identifies UBE2C-Independent
Function of UBE2S in Mitotic K11-Linked
Ubiquitylation
(A) Generation of UBE2S- and UBE2C-knockout
HCT116 cells. Western blot analysis shows
UBE2S and UBE2C levels in the indicated cell
lines.
(B) NEBD-to-anaphase onset times in the indi-
cated cells were measured by time-lapse differ-
ential interference contrast (DIC) microscopy.
Each circle represents a single cell; open circles
indicate cells that completed mitosis and red-fil-
led circles indicate cells that did not exit mitosis
within the stated time. The red line indicates
median NEBD-to-anaphase onset time, which is
noted on the top of the respective data points.
For each cell line, at least 145 cells were analyzed
from at least four independent experiments. The
p values were calculated with Mann-Whitney
tests.
(C) Cells were treated with the indicated
concentrations of proTAME and NEBD-to-
anaphase onset timing was measured by live-
cell imaging (DIC), as in (B). At least 70 cells
were analyzed from two independent experi-
ments. The median is depicted as a red line
and noted above the data points. The p values
for the indicated conditions are stated on top
(ns, p R 0.01).
(D) Analysis of K11-linked polyubiquitin chains in
unsynchronized and mitotically enriched cells for
the indicated cell lines. CCNB1 levels are shown to
confirm enrichment of mitotic cells.can acquire a genetic state in which the SAC becomes
unessential.
RESULTS
UBE2C and UBE2S Are Dispensable for Mitosis and Cell
Viability
To investigate the requirement of E2s for APC/C activity in
mitosis, we generated UBE2C- and UBE2S-knockout (DUBE2C
and DUBE2S) HCT116 (a human colorectal carcinoma cell line)
cells using the clustered regularly interspaced short palin-
dromic repeats (CRISPR)/Cas9 technology (Cong et al., 2013;
Mali et al., 2013; Figure 1A). Function of the APC/C in these
cells was assessed by quantifying the duration of nuclear
envelope breakdown (NEBD) to anaphase onset (Figure 1B).
Compared to wild-type (WT) cells, DUBE2C cells displayed a
significant (p < 0.0001) delay in anaphase onset after NEBD,
whereas ablation of UBE2S caused only a relatively minor
delay. These results showed that UBE2S and UBE2C have a
function in mitosis, but they are not essential for mitosis and
cell viability. To confirm whether mitotic delay in DUBE2C
cells resulted from impaired APC/C activity, we assayed the
sensitivity of these cells to proTAME, a small molecule inhibitor
of the APC/C (Zeng et al., 2010). Indeed, DUBE2C cells dis-1830 Cell Reports 14, 1829–1840, March 1, 2016 ª2016 The Authorsplayed a greater sensitivity to proTAME compared to WT and
DUBE2S cells (Figure 1C), consistent with impaired APC/C
activity in these cells. This result is also in agreement with the
prolonged NEBD-to-anaphase onset timing in DUBE2C cells
(Figure 1B).
UBE2S Can Generate K11-Linked Polyubiquitin Chains
in the Absence of UBE2C
Because UBE2S alone cannot initiate APC/C-mediated ubiqui-
tylation (Garnett et al., 2009), it is conceivable that DUBE2C
cells also lack UBE2S-dependent APC/C function, possibly
explaining the more severe phenotypes seen in DUBE2C
cells compared to DUBE2S cells. To test this hypothesis,
we assessed the mitosis-specific increase in K11-linked
ubiquitylation, which depends on UBE2S activity (Williamson
et al., 2009). We observed a strong increase in K11 linkages
in mitotically enriched WT cells, and, consistent with previous
RNAi-based data (Matsumoto et al., 2010; Williamson et al.,
2009), this increase was abrogated in DUBE2S cells (Figure 1D).
While deletion of UBE2C reduced mitotic K11 ubiquitylation,
a significant pool of K11-linked ubiquitin was still present
in these cells, clearly demonstrating that in vivo UBE2S
also can generate polyubiquitin chains independently of
UBE2C.
APC/C Activity Is Severely Impaired in UBE2C and
UBE2S Double Knockouts
The inability of UBE2S to initiate APC/C-dependent ubiquityla-
tion (Garnett et al., 2009; Williamson et al., 2009; Wu et al.,
2010) suggested that the viability of DUBE2C cells (Figure 1A;
Li et al., 2014) cannot be explained by the presence of UBE2S
in these cells. Instead, the presence of K11-linked ubiquitylation
in mitotically enriched DUBE2C cells, but not in DUBE2S cells,
suggested that UBE2S extends ubiquitylation catalyzed by
another E2 that cooperates with the APC/C to initiate substrate
ubiquitylation. Therefore, we surmised that such an E2 may be
sufficient to provide minimum APC/C function in the absence
of UBE2C and UBE2S. Indeed, by deleting UBE2C in DUBE2S
cells, we were able to obtain four clonal cell lines (#3, #4, #8,
and #12) that were deficient for both APC/C-specific E2s
(Figure 2A). NEBD-to-anaphase onset timing was severely pro-
longed in DUBE2SDUBE2C cell clones (Figure 2B). Thus, simul-
taneous deletion ofUBE2S andUBE2C has an aggravated effect
on mitotic progression compared to deletion of either gene indi-
vidually. This result further points to UBE2S function that is inde-
pendent of UBE2C, consistent with the notable increase in
mitotic K11 linkages in DUBE2C cells (Figure 1D). The APC/C
is essential for mitosis and it is, therefore, unlikely that DUBE2S-
DUBE2C entirely lacked APC/C function. To formally test the
APC/C activity in the absence of UBE2S and UBE2C, we treated
DUBE2SDUBE2C cells with proTAME. Compared to WT cells,
DUBE2SDUBE2C cells displayed a markedly increased sensi-
tivity to proTAME (Figure 2C), providing evidence for the activity
of the APC/C in these cells and demonstrating that the APC/C
can function without these two E2s.
UBE2D Functions with the APC/C In Vivo
The above results clearly indicate a role of another (separate
from UBE2C and UBE2S) E2 enzyme in APC/C function.
In vitro, UBE2D can support APC/C-dependent substrate ubiq-
uitylation, and UBE2S can promote subsequent polyubiquityla-
tion of these substrates (Garnett et al., 2009). Thus, UBE2D
is an attractive candidate that could mediate UBE2C- and
UBE2S-independent APC/C activity, but previous studies have
questioned its functional relevance in vivo (Bastians et al.,
1999; Jin et al., 2008; Williamson et al., 2009). To test whether
UBE2D mediates APC/C activity in DUBE2SDUBE2C cells,
UBE2Dwas depleted in these cells using RNAi. The UBE2D fam-
ily of E2s is among themost promiscuous and can functionwith a
large number of E3 enzymes (Komander andRape, 2012). There-
fore, to minimize pleiotropic effects of strong UBE2D depletion,
we established RNAi conditions resulting in a relatively modest
knockdown (Figure S1A). While modest UBE2D depletion
had no discernible effect on mitosis in WT cells, all tested
DUBE2SDUBE2C cell clones displayed a significantly prolonged
mitosis upon UBE2D knockdown (Figure 2D; Figure S1A).
Notably, UBE2D knockdown also exacerbated the mitotic delay
inDUBE2C cells, but not inDUBE2S cells (Figure 2E; Figure S1B).
The most likely explanation for this observation is that UBE2S
cannot function in the absence of UBE2C and UBE2D, which is
consistent with biochemical data showing that UBE2S can
extend ubiquitin linkages but cannot initiate substrate ubiquityla-
tion. Together, these results show that UBE2C and UBE2D canCeprovide sufficiently robust APC/C function in the absence of
UBE2S and that they function independent of each other with
the APC/C. While UBE2D alone can support minimal APC/C
activity, its function is notably strengthened by the presence
of UBE2S, most likely by extending UBE2D-dependent, APC/
C-initiated ubiquitylation. Together, our results establish that
three E2 enzymes, UBE2C, UBE2S, and UBE2D, function as
bona fide partners for the APC/C in vivo.
DUBE2SDUBE2C Cells Lose Switch-like Metaphase-to-
Anaphase Transition
To better understand the basis for the delay in NEBD to
anaphase onset in DUBE2SDUBE2C cells, we measured the
duration of NEBD to metaphase plate formation and to subse-
quent anaphase onset (Figures S2A and S2B). DUBE2SDUBE2C
cells required a longer time to establish the metaphase plate and
showed delays in the metaphase-to-anaphase transition, indi-
cating that APC/C function in these cells is severely impaired
(Figure S2A). To more directly assess mitotic APC/C activity in
the knockout cells, we analyzed the degradation kinetics of
Venus-tagged endogenous CCNB1 (cyclin B1), a key substrate
of the APC/C for mitotic exit (Irniger et al., 1995; King et al.,
1995; Sudakin et al., 1995). In WT cells, as well as in DUBE2S
and DUBE2C single-knockout cells, CCNB1 was degraded
rapidly after the establishment of the metaphase plate (Figures
2F and 2G; Figures S3A and S3B), but CCNB1 degradation
was significantly impaired in DUBE2SDUBE2C cells. These re-
sults show that reduced APC/C activity, due to simultaneous
deletion of UBE2S and UBE2C, leads to loss of rapid onset of
CCNB1 degradation upon establishment of the metaphase
plate. Thus, the strength of the APC/C is important for switch-
like metaphase-to-anaphase transition.
Lowering APC/C Activity Renders the SAC Non-
essential for Cell Viability
During mitosis, formation of the metaphase plate leads to SAC
inactivation and triggers APC/C activation, which in turn prompts
rapid anaphase onset. Therefore, to test SAC activity in
DUBE2SDUBE2C cells, we treated cells with nocodazole, which
inhibits microtubule polymerization and potently activates the
SAC. As expected, nocodazole treatment caused severe mitotic
arrest in WT as well as in DUBE2C and DUBE2S single-knockout
cells (Figure 3A). Interestingly, one of the DUBE2SDUBE2C
clones displayed a marked insensitivity to nocodazole, indi-
cating a severely compromised SAC in this particular cell line.
Because the SAC is indispensable for mammalian cells, severe
insensitivity of DUBE2SDUBE2C #4 to nocodazole indicated
that SAC may not be essential for viability of these cells.
This prompted us to directly assess the requirement of SAC
function for viability of all DUBE2SDUBE2C cell clones. We
treated cells with reversine to inhibit the kinase MPS1 that is
essential for initiating the SAC (Abrieu et al., 2001; Fisk and
Winey, 2001; Santaguida et al., 2010). Inhibition of MPS1
results in improper chromosome segregation, which invariably
results in cell death. Reversine potently inhibited proliferation
of WT, DUBE2S, and DUBE2C cells (Figure 3B), confirming
that MPS1 activity is essential for these cells. Strikingly, all
DUBE2SDUBE2C cell clones, irrespective of their SAC activityll Reports 14, 1829–1840, March 1, 2016 ª2016 The Authors 1831
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Figure 2. Genetic Deletion of APC/C-Spe-
cific E2s Uncovers In Vivo Function of
UBE2D in APC/C Activation
(A) Four independentDUBE2SDUBE2C cell clones
were generated, and deletion of UBE2S and
UBE2C was confirmed by immunoblotting.
(B) NEBD-to-anaphase onset times in
DUBE2SDUBE2C cells, analyzed as described in
Figure 1B. For each cell line, at least 87 cells were
analyzed from four independent experiments.
(C) Cells were treated with the indicated concen-
trations of proTAME and NEBD-to-anaphase
onset timing was measured by live-cell imaging
(DIC). At least 55 cells were analyzed from two
independent experiments. The red line indicates
the median NEBD-to-anaphase time, which is
noted above the data points. The p values
for the indicated conditions are stated on top (ns,
pR 0.01).
(D) NEBD-to-anaphase onset timing was analyzed
as described in Figure 1B. 24 hr prior to filming,WT
and the indicated DUBE2SDUBE2C cell clones
were treated with small interfering RNAs (siRNAs)
targeting UBE2D (+) or control () siRNA. For each
condition, at least 113 cells were analyzed from
three independent experiments (ns, pR 0.01).
(E) Cells were treated with siRNAs targeting
UBE2D (+) or control siRNA (), and NEBD-to-
anaphase onset timing was measured by live-cell
imaging (DIC). At least 95 cells were analyzed from
three independent experiments. The median is
depicted as a red line and the median time is
shown above the data points. The p values
for the indicated conditions are stated on top (ns,
pR 0.01).
(F) CCNB1 degradation curves for the indicated
cell lines. One allele of CCNB1 was tagged with
Venus, and degradation of CCNB1-Venus was
analyzed by live-cell imaging. Time = 0 is set to two
frames before the beginning of CCNB1 degrada-
tion, which was defined as a decrease in CCNB1-
Venus intensity of >4%. The curves depict mean
CCNB1-Venus fluorescent intensity from analyzed
cells (from time = 0 to five time frames after
anaphase onset), and the one-sided error bars
show the SD.
(G) CCNB1 degradation rates were calculated
from the experiment shown in (F). The best linear fit
around the maximum difference in CCNB1-Venus
intensities (normalized to NEBD) between two time
points was determined, and the corresponding
slopes are plotted. The mean values are noted on
the top of the data points and depicted as a red line
with SDs emerging as vertical lines. The p values
were calculated with t tests (ns, pR 0.01).
See also Figures S1–S3.in nocodazole experiments (Figure 3A), grew in the presence
of reversine (Figure 3B; Figure S4A). The resistance of
DUBE2SDUBE2C cells to reversine indicated that the SAC is
not essential in DUBE2SDUBE2C cells.
To unequivocally test this, we tried to genetically delete
MAD2, an essential gene and key component of the SAC
(Michel et al., 2004), in DUBE2SDUBE2C cells. We used two1832 Cell Reports 14, 1829–1840, March 1, 2016 ª2016 The Authorsindependent DUBE2SDUBE2C cell clones (#3 and #4), which
differed in their sensitivity to nocodazole and, thus, in SAC func-
tionality (Figure 3A). Indeed, we succeeded in obtaining MAD2-
deficient cells in the DUBE2SDUBE2C background (Figure 3C;
Figure S4B), clearly demonstrating that the SAC function is no
longer essential after UBE2C and UBE2S deletion. As expected,
in WT cells, RNAi against MAD2 resulted in aberrant mitosis, as
marked by accelerated mitotic timing and failure to form a
proper metaphase plate (Figure 3D; Figures S4C–S4F). Notably,
DUBE2SDUBE2CDMAD2 cells displayed normal metaphase
plate formation and segregation of chromosomes despite
complete lack of MAD2. Thus, the mitotic phenotype of
DUBE2SDUBE2CDMAD2 cells is dissimilar from WT cells
depleted of MAD2 by RNAi and, rather, they resemble control
WT cells (Figure 3D). Genetic deletion of SAC components re-
sults in grossly abnormal mitosis, and these mitosis-incompe-
tent cells eventually are eliminated through cell death. Thus,
viability of DUBE2SDUBE2CDMAD2 cells, without gross abnor-
malities in chromosomal separation, is striking. We speculate
that prolonged mitotic timing in DUBE2SDUBE2CDMAD2 cells,
compared to WT cells (Figure S4C), may be sufficient to allow
for proper chromosome alignment in the absence of a functional
SAC. Consistent with this notion, inhibition of the SAC by
reversine in WT, DUBE2S, and DUBE2C cells caused massive
polyploidy (Figure 3E). In stark contrast, reversine had no
observable effect on the ploidy of DUBE2SDUBE2C and
DUBE2SDUBE2CDMAD2 cells (Figure 3E; Figure S4G). These
results establish that the SAC activity becomes dispensable
for proliferation in human cells lacking both UBE2S and
UBE2C. Thus, reducing APC/C activity confers synthetic
viability to MPS1 inhibition and MAD2 deletion.
Distinct Consequences of SAC Inhibition in
DUBE2SDUBE2C and TP53-Knockout Cells
Apreviousstudy reportedviability ofmurineembryonic fibroblasts
(MEFs) with simultaneous deletion of TP53 and MAD2 (Burds
et al., 2005). However, unlike our DUBE2SDUBE2CDMAD2
HCT116cells, the reportedDTP53DMAD2MEFsshowedextreme
chromosome instability (with >50% of mitotic cells showing
chromosome missegregation) and aneuploidy. To directly com-
pare theconsequenceofTP53deletionand theAPC/Cweakening
upon SAC inactivation in human cells, we used HCT116 TP53-
knockout cells (Bunz et al., 1998) and inactivated the SAC by
two different approaches as follows: (1) inhibiting the kinase
MPS1 with reversine, and (2) knocking down MAD2 using RNAi.
In contrast to DUBE2SDUBE2C cells, proliferation of TP53-
knockout cells was inhibited by reversine, albeit they showed
improved viability compared to WT cells (Figure 4A). Also,
reversine-treated WT and TP53-knockout cells were multi-
nucleated and grossly polyploid; in sharp contrast, the
ploidy of DUBE2SDUBE2C cells was not affected by reversine
treatment (Figures 4B and 3E). Ablation of MAD2 accelerated
mitosis in WT, DUBE2SDUBE2C, and TP53-knockout cells
(Figure 4C). Notably, the mitotic duration of MAD2-depleted
DUBE2SDUBE2C cells, but not MAD2-depleted TP53-knockout
cells, was comparable to the mitotic duration of untreated
WT cells (i.e., not depleted of MAD2). Consistent with these
results, MAD2 depletion in TP53-knockout cells resulted in
severe problems in chromosome segregation compared to
DUBE2SDUBE2C cells (Figure 4D). Thus, our results demonstrate
that in human cells deletion of TP53 is not sufficient to prevent
chromosome segregation problems caused by SAC inactivation.
These results show that the consequences of TP53 deletion and
lowering the APC/C activity on the requirement of the SAC are
fundamentally distinct.CeWeak SAC Activity Can Be Beneficial in Cells with
Compromised APC/C Function
To explore how DUBE2SDUBE2C #4 reduced SAC activity (Fig-
ure 3A), we quantified changes in protein expression using stable
isotope labeling by amino acids in cell culture (SILAC)-based
proteomics (Table S1). Notably, we found that levels of MPS1
were reduced in this clone, and this observation subsequently
was confirmed independently by western blotting (Figure 5A).
Because MPS1 is essential for activation of the SAC, we
reasoned that the downregulation of MPS1 specifically in this
clone could have led to reduced SAC activity. Consistently,
ectopic expression of TFP-MPS1 in these cells restored SAC ac-
tivity (Figure 5B). The SAC-generated MCC is a direct inhibitor of
the APC/C; thus, it is an attractive possibility that dampening of
SAC activity, for example, by downregulating MPS1, could actu-
ally be beneficial in the context of low APC/C activity.
To test this hypothesis, we wished to generate new
DUBE2SDUBE2C cells in which SAC activity could be restored
at will. To do this, we deleted UBE2C in DUBE2S cells in
the presence of reversine, thereby chemically mimicking the
low MPS1 levels observed in the DUBE2SDUBE2C #4 (Fig-
ure 5C). Using this approach, we obtained double-knockout
cell clones (termed DUBE2SDUBE2C-R), and, unless indicated,
these cells were cultured continuously in reversine (Figure 5D).
To test if SAC inactivation in these cells is inconsequential or
beneficial, we restored SAC function by removing reversine and
assessed their proliferation. Indeed, DUBE2SDUBE2C-R cells
grew better in the presence of reversine than in its absence
(Figure 5E). It should be noted that reversine treatment resulted
in a reduction in proliferation of both DUBE2SDUBE2C and
DUBE2SDUBE2CDMAD2 cells (Figure 3B; Figures S5A and
S5B), indicating a SAC inhibition-independent adverse effect
of reversine on cell proliferation. Thus, we interpret that, in
DUBE2SDUBE2C-R cells, the benefit of reversine-mediated
SAC inhibition outweighs the SAC-independent growth disad-
vantage caused by reversine. In agreement with this, removal
of reversine in DUBE2SDUBE2C-R cells led to increased timing
fromNEDB toanaphaseonset (Figure 5F), asNEDB-to-anaphase
onset timingwasalmost doubled3daysafter removing reversine.
Importantly, the increase inmitotic timing after reversine removal
wasSACdependent, as depletion ofMAD2byRNAi substantially
ameliorated this defect (Figure 5G). Hence, low SAC activity can
be of avail for cells with critically low APC/C activity.
DISCUSSION
In this work we report several findings: (1) we show that UBE2S
can catalyze mitotic K11 ubiquitin linkages in vivo in the com-
plete absence of UBE2C and that the deletion of UBE2S in
UBE2C background causes a more pronounced cellular pheno-
type than deletion of UBE2C alone, thus revealing an important
function of UBE2S that is independent of UBE2C. (2) We show
that UBE2C-UBE2S double-knockout cells are viable. While
mitosis in these cells was severely prolonged, their viability dem-
onstrates that the APC/C can function without its known physio-
logical E2 module (Jin et al., 2008; Williamson et al., 2009;
Wickliffe et al., 2011). (3) We provide in vivo evidence that
UBE2D functions with the APC/C in mitosis, which is consistentll Reports 14, 1829–1840, March 1, 2016 ª2016 The Authors 1833
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with previous in vitro data (Garnett et al., 2009; Summers et al.,
2008; Williamson et al., 2009; Wu et al., 2010) and a recently re-
ported function of UBE2D3 in meiosis of murine oocytes (Ben-
Eliezer et al., 2015). (4) We show that a reduction in APC/C
function provides synthetic viability to SAC inactivation, as cells
lacking MAD2 and MPS1 functions are viable in the context of
low APC/C activity.
Our results establish that in human cells the activity of the
APC/C is powered by three different E2s: UBE2C, UBE2S, and
UBE2D. Deletion of UBE2S, which catalyzes mitosis-specific
K11-linked ubiquitylation, only modestly affected mitotic timing.
These results are consistent with previous RNAi-based studies
(Meyer and Rape, 2014; Williamson et al., 2009), and they clearly
show that weakmitotic phenotypes observed in previous studies
are not due to incomplete knockdown of UBE2S. These results
show that UBE2S, and thus UBE2S-catalyzed mitotic upregula-
tion of K11 linkages, is not absolutely essential for mitotic pro-
gression. Deletion of APC/C-associated E2s, individually and in
combination, allowed us to establish an important function of
UBE2S in mitosis, as we demonstrate that DUBE2SDUBE2C
cells have significantly prolonged mitosis timing compared to
DUBE2C cells. Previous studies have shown that RNAi-medi-
ated depletion of UBE2C together with UBE2S stabilizes APC/
C substrates and delays mitosis more efficiently than either sin-
gle depletion (Williamson et al., 2009). However, these results
were interpreted as evidence for UBE2C andUBE2S constituting
a functional pair for APC/C-mediated ubiquitylation and not as
evidence for an UBE2C-independent function of UBE2S. In this
work we reveal an UBE2C-independent function of UBE2S.
Our results are consistent with the emerging notion that
UBE2S-catalyzed polyubiquitylation of APC/C substrates is not
absolutely necessary for their degradation but can increase the
rate of substrate degradation (Dimova et al., 2012; Garnett
et al., 2009; Meyer and Rape, 2014).
While UBE2C and UBE2S are APC/C-specific E2 enzymes,
the UBE2D family of E2s functions in conjunction with many
(possibly hundreds of) E3 enzymes and has been implicated in
many other cellular processes (Komander and Rape, 2012).
Thus, it is difficult to genetically assess the relative contribution
of UBE2D to APC/C function in vivo. Regardless, we show thatFigure 3. UBE2S and UBE2C Jointly Render the SAC Essential for Cell
(A) NEBD-to-anaphase onset timing for the indicated cell lines upon nocoda
circle represents a single cell (red-filled circles indicate cells that did not exit mitos
experiments. The median is depicted as a red line and noted above the data po
Whitney tests (ns, pR 0.01).
(B) Growth analysis of the indicated cell lines in the presence or absence of 0.5
luminescence-based assay measuring ATP levels. A local regression curve is plot
point.
(C) Generation of UBE2S, UBE2C, andMAD2 triple-knockout cells. The immunob
#3 and the triple-knockout clone.
(D) Comparison of mitotic phonotypes ofMAD2-deleted DUBE2SDUBE2C #3 cel
transfected with RFP-tagged histone H2B were monitored by live-cell imaging a
types. At least 27 cells were analyzed from three independent experiments.
(E) The histograms depict DNA content (2N, 2–4N, and >4N; N approximates a ha
(0.5 mM) for the indicated time (hr). The inlays show percentages of cells with the
mean ± SDs from three independent experiments. DNA content was analyzed by
minimum of 9,000 cells were analyzed for each condition. The histograms show
See also Figure S4.
CeDUBE2SDUBE2C cells display a pronounced mitotic delay
and reduced CCNB1 degradation compared to DUBE2C cells,
clearly indicating that the APC/C can initiate its substrate ubiqui-
tylation independent of UBE2C. Furthermore, we show that
knockdown of UBE2D in DUBE2C cells exacerbates mitotic
delay and that UBE2S can catalyze K11-linked polyubiquityla-
tion in mitotic DUBE2C cells, likely by extending UBE2D-APC/
C-initiated ubiquitylation. These findings, and previous reports
that UBE2D can promote APC/C-dependent ubiquitylation
in vitro (Garnett et al., 2009; Williamson et al., 2009; Wu et al.,
2010; Yu et al., 1996), support the functional relevance of
UBE2D in mediating APC/C activity in vivo. Importantly, we did
not observe increased UBE2D levels upon deletion of UBE2C
(Figure S1; Table S1), indicating that normal cellular UBE2D
levels are sufficient to result in notable UBE2D-dependent
APC/C activity. We speculate that UBE2D could provide basal
activity to the APC/C, and mitosis-specific upregulation of
UBE2C and UBE2S leverages the APC/C to its maximum power.
Thus, the combinatorial use of the three different E2s confers
robustness and tunability to mitotic APC/C activity. This also
may explain why we, and other researchers (Bastians et al.,
1999; Jin et al., 2008; Williamson et al., 2009), have failed to
note a clear mitotic phenotype upon UBE2D depletion in WT
cells, as the other two E2s would maintain sufficient APC/C ac-
tivity upon UBE2D depletion.
Importantly, this work shows that it is the strength of the
APC/C, powered by three cooperating E2s, that renders the
SAC essential in human cells. In a simple model, the APC/C
and the SAC can be viewed as mitotic accelerator and brake,
respectively. While the accelerator is strictly required to progress
through mitosis, the brake is only needed in proportion to the
strength of the accelerator and a strong brake could even be
detrimental to cells with a weak accelerator. Notably, the SAC
is essential in all metazoans, with the exception of Drosophila
(Buffin et al., 2007). To the best of our knowledge, we report
the first example of long-term viable human cells lacking the
SAC. Lowering APC/C activity renders the SAC non-essential
in human cells, which normally rely on SAC activity for viability,
possibly by extending the available time for aligning the chromo-
somes. Interestingly, genetic screens in C. elegans identifiedViability
zole treatment (30 ng/ml) measured by time-lapse microscopy (DIC). Each
is within the stated time). At least 61 cells were analyzed from two independent
ints. The p values for the indicated comparisons were calculated with Mann-
mM reversine. Cell proliferation was assessed at the indicated times using a
ted for each cell line and condition based on at least six measurements per time
lot confirms deletion of the indicated proteins in the parental DUBE2SDUBE2C
ls with WT cells in whichMAD2 was knocked down with RNAi. Cells transiently
nd classified into categories representing normal and aberrant mitotic pheno-
ploid genome) in the specified cells that were cultured with or without reversine
indicated DNA content for the specified cells and conditions; the values show
propidium iodide staining and flow cytometric analysis. For each experiment, a
representative data from one of the experiments. rev, reversine.
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Figure 4. Analysis of SAC Inhibition in DUBE2SDUBE2C and TP53-Knockout Cells
(A) Growth analysis of DUBE2SDUBE2C cells and TP53-knockout cells in the presence or absence of 0.5 mM reversine. Cell proliferation was assessed at the
indicated times using a luminescence-based assay measuring ATP levels. A local regression curve is plotted for each cell line and condition based on at least six
measurements per time point.
(B) Inhibition of MPS1 causes polyploidy in HCT116 WT and DTP53 cells, but not in DUBE2SDUBE2C cells. Cells were treated with reversine for 4 days, and
mediumwas changed after 2 days in culture. Cellular DNAwas stained with Hoechst and imaged using a wide-field microscope. The scale bar represents 20 mm.
(C) Knockdown ofMAD2 accelerates mitotic progression. Cells transiently transfected withMAD2 siRNAs and RFP-tagged histone H2Bweremonitored by time-
lapsemicroscopy. NEBD to anaphase onset for the indicated cell lines was analyzed; each circle represents a single cell. The p valueswere calculated withMann-
Whitney tests.
(D) Comparison of mitosis of WT, DUBE2SDUBE2C, and DTP53 cells upon MAD2 knockdown. Formation of the metaphase plate in mitotic cells was analyzed
from the experiment shown in (C). Note that knockdown of MAD2 in WT and DTP53 cells leads to gross problems in metaphase plate formation.temperature-sensitive mutations in APC/C subunits and its
mitotic co-activator CDC20 as suppressors of the lethality
caused by loss of the essential SAC component MAD1 (Furuta1836 Cell Reports 14, 1829–1840, March 1, 2016 ª2016 The Authorset al., 2000; Kitagawa et al., 2002; Tarailo et al., 2007). These
studies established that in C. elegans a mitotic delay can
compensate for the lack of the normally essential SAC. In line
with this notion, our results demonstrate that in human cells the
only essential function of the SAC is to restrain the APC/C activity
in mitosis in order to provide sufficient time for aligning the
chromosomes to the metaphase plate.
A previous study (Burds et al., 2005) showed that simultaneous
deletion of TP53 andMAD2 led to very high rate of chromosome
instability. Importantly, our engineered (DUBE2SDUBE2C) cells
are viable without the SAC in the presence of p53. We demon-
strate that the consequences of TP53 inactivation and the
reduction in the APC/C activity upon inactivation of SAC function
are fundamentally different. The key distinction is that deletion
of UBE2C and UBE2S prevents SAC inactivation-triggered
aneuploidy, whereas deletion of TP53 does not. Without the
SAC,deletionofTP53canapparently dampen theconsequences
of a catastrophic mitosis (i.e., polyploidy-driven apoptosis),
whereas weakening of the APC/C (by means of UBE2C and
UBE2S deletion) prevents this catastrophic mitosis in the first
place.
Small molecule inhibitors of MPS1 and the APC/C are being
explored for therapeutic targeting of cancers (Liu and Winey,
2012; Sackton et al., 2014; Zeng et al., 2010). Here we discov-
ered a genotype, DUBE2SDUBE2C, that allows cells to tolerate
chemical inhibition of MPS1, providing possible means of resis-
tance. Inversely, incomplete APC/C inhibition could be compen-
sated by reduced SAC activity, as shown here genetically and
previously observed with chemical APC/C inhibitors (Lara-Gon-
zalez and Taylor, 2012; Zeng et al., 2010). Clearly, the interplay
between SAC and APC/C activities is an important determinant
of cellular behavior upon interference with mitosis, and, hence,
therapeutic targeting of these key mitotic machines warrants
further consideration.
EXPERIMENTAL PROCEDURES
Genome Editing
TheUBE2S-,UBE2C-, andMAD2-knockout HCT116 cells were generated us-
ing the CRISPR/Cas9 technology (Cong et al., 2013; Mali et al., 2013). A donor
plasmid containing a splice acceptor site and a resistance marker gene (puro-
mycin, blasticidin, or hygromycin), flanked by homology arms, was co-trans-
fected with pX330 (Cong et al., 2013), targeting the indicated DNA sequence
within the respective gene. After drug resistance selection, cell colonies
were screened by western blotting for the loss of the respective protein.
DUBE2SDUBE2C-R cells were generated from DUBE2S cells by targeting
UBE2C in the presence of reversine (0.5 mM). The following targeting sites
were used: CCTCGGGCCCATCCCGGGTC for UBE2S (puromycin selection),
CCACTAGCGTCGCCGCCGCC for UBE2C (blasticidin selection), and
CACCCCTTACTTTCCGATAC and TACAGGACACGGTGTGACTG for MAD2
(hygromycin selection). CCNB1 was endogenously tagged with Venus using
recombinant adeno-associated virus (rAAV)-based genome engineering. The
pAAV-CCNB1-Venus-targeting construct (Collin et al., 2013) was packed
into rAAV particles in HEK293 cells as described previously (Berdougo et al.,
2009). HCT116 WT, DUBE2S, DUBE2C, and DUBE2SDUBE2C #3 cells were
infected with viral supernatant for 48 hr and expanded for 4 days post-
infection. Mitotically enriched cells were collected and sorted using a BD
FACSAria III sorter (BD Biosciences). Venus-positive single cells were individ-
ually sorted into single wells of a 96-well imaging plate; 12–16 days after the
cell sorting, a screen for correctly targeted clones was performed using auto-
mated wide-field microscopy on an Olympus ScanR system (motorized IX81
microscope) with ScanR Image Acquisition Software, using an UPLSAPO
103/0.4 numerical aperture (NA) dry objective and a MT20 Illumination sys-
tem. Clones that exhibited Venus expression and the expected localization
of CCBN1-Venus were retained and confirmed by western blotting.CeLive-Cell Imaging
Cells grown in an eight-well chamber (Ibidi) with L-15 medium supplemented
with 10% fetal bovine serum (FBS) were mounted on a DeltaVision Elite
microscope (GE Healthcare) and imaged using a 403 oil-immersion objective
(1.35 NA, working distance [WD] 0.10). Images (differential interference
contrast [DIC], yellow fluorescent protein [YFP], and red fluorescent protein
[RFP]) were acquired continuously for 18–20 hr with 4- or 5-min intervals taking
z stacks of 7 mm. Data analysis was performed using the softWorx software
(GE Healthcare). ImageJ (NIH) was used to extract still images. The time
from NEBD to anaphase onset was measured from the frame in which the
nuclear envelope had disappeared to the frame in which the chromosomes
had started to separate, as observed in DIC images. Each cell is represented
in the graphs as a single circle. Red-filled circles indicate cells that did not exit
mitosis within the time shown (e.g., due to end of filming) and, hence, represent
a lower estimate.
CCNB1-Venus intensity was measured using the softWorx software (GE
Healthcare) and time = 0 was set to two frames before initial CCNB1 degrada-
tion. The beginning of CCNB1 degradation was defined as a decrease in
CCNB1-Venus intensity of >4%. Normalization to the beginning of CCNB1
degradation, rather than metaphase plate formation, was done to compare
CCNB1 intensity decrease while eliminating mistakes of wrongly classifying a
platewith subtlealignmenterrorsasanerror-freeplate.TheCCNB1degradation
curvesdepict cells from time=0 to five framesafter anaphaseonset (the curve is
depicted until all but one cell reached five frames after anaphase onset). To
quantify differences in CCNB1 degradation, we calculated degradation rates
around the maximum degradation. Background intensity was subtracted from
the raw data and CCNB1 intensity was normalized to CCNB1 intensity at
NEBD. The maximum difference in CCNB1 intensities between two time points
wascalculated to identify the timeofmaximalCCNB1degradation.At least three
timepointswereused, including the two timepointsatmaximumdegradation, to
find the best fit to linear regression (highest R-squared value). The slope of the
resulting linear regression gives the CCNB1 degradation rates around maximal
CCNB1 degradation. Medians for mitotic timing (NEBD to anaphase onset and
NEBD tometaphase ormetaphase to anaphase onset) are depicted as red lines
and stated on top of the graphs. The p values were calculated withMann-Whit-
ney tests. Means for CCNB1 degradation rates are depicted as a red line with
SDs as vertical lines emerging from it, and stated on top of the graph. The
p values were calculated with t tests. For statistical analysis, Prism (GraphPad
software) was used; p valuesR 0.01 were defined as non-significant.
Antibodies Used for Western Blotting
The following antibodieswere used: UBE2S (Cell Signaling Technology, 9630S
or Abnova, PAB1701), Ubiquitin K11 linkage (Millipore, MABS107, clone 2A3/
2E6), UBE2C (Boston Chemicals, A-650), MAD2 (Bethyl Laboraratories, A300-
301A or homemade mouse antibody raised against full-length MAD2), CCNB1
(BD Pharmingen, 554176), MPS1 (Abcam, ab11108), Tubulin (Sigma-Aldrich,
T5326 or Abcam, ab6160), GAPDH (Abcam, ab8245), UBE2D (Abcam,
ab155088), Vinculin (Sigma, V9131), and GFP (Abcam, ab290).
Cell Synchronization
To synchronize cells in mitosis, cells were cultured in thymidine- (2.5 mM) con-
taining medium for 18 hr, released into medium without thymidine for 8 hr, and
again cultured for 18 hr in medium containing thymidine (2.5 mM). After release
from the second thymidine block into medium without thymidine, mitotic cells
were harvested by shake-off at the mitotic peak (10 hr after release from the
thymidine block).
Cellular DNA Analysis by Microscopy
Cells grown on coverslips were fixed with 4% paraformaldehyde (in PBS),
stained with Hoechst (1 mg/ml in PBS), and mounted on coverslides using
Vectashield as mounting medium. Microscopy was performed with a Leica
wide-field system (DMI6000 B) using a 403 objective.
Drug Treatments for Microscopy-Based Live-Cell Imaging
Experiments
The APC/C inhibitor proTAME (Boston Biochem) was used at the indicated
concentrations (5, 10, or 15 mM). To evaluate SAC activity, nocodazole wasll Reports 14, 1829–1840, March 1, 2016 ª2016 The Authors 1837
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Figure 5. Inhibition of the SAC Confers Beneficial Effects to Cells with Compromised APC/C Activity
(A) Western blot analysis of MPS1 levels in WT and the indicated DUBE2SDUBE2C cell clones is shown.
(B) NEBD-to-anaphase onset timing in DUBE2SDUBE2C #4 in the presence or absence of nocodazole and upon TFP-MPS1 transfection in the presence of
nocodazole. At least 30 cells were analyzed from three independent experiments. The median is depicted as a red line and noted above the data points. The
p values for indicated conditions are stated on top.
(C) Schematic outline for the generation of DUBE2SDUBE2C-R cells. UBE2C was deleted in DUBE2S cells in the presence of reversine.
(D) Western blot analysis of UBE2S and UBE2C levels in WT and the indicated DUBE2SDUBE2C-R cell clones is shown.
(E) Growth analysis of the indicated cell lines in the presence or absence of 0.5 mM reversine. Cell proliferationwas assessed for the indicated cells and times using
a luminescence-based assay measuring ATP levels. A local regression curve is plotted for each cell line and condition based on at least six measurements per
time point.
(F) Analysis of NEBD-to-anaphase onset timing by time-lapsemicroscopy (DIC). Each circle represents a single cell (red-filled circles indicate cells that did not exit
mitosis within the stated time). WT cells were cultured with the following conditions: control, no reversine; rev, reversine added at the start of the experiment; and
washout, cells cultured with reversine for 24 hr and reversine was removed just prior to the start of filming.DUBE2SDUBE2C-R cells were cultured in the following
conditions: rev, cells were continuously cultured in reversine; days after washout, reversine was washed out from cells that were continuously cultured in
reversine and filmed after the indicated number of days after reversine removal. The median NEBD-to-anaphase onset time is depicted as a red line and noted
above the data points. At least 41 cells were analyzed from each cell line and condition. The p values were calculated with Mann-Whitney tests (ns, pR 0.01).
(legend continued on next page)
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used at 30 ng/ml and reversine was used at 0.5 mM. Drugs were added to cells
upon change to L-15 medium on the day of filming (1–2 hr prior to filming). To
remove reversine from DUBE2SDUBE2C-R cells, cells were washed twice
with PBS at indicated times and subsequently cultured in medium without
reversine.
Transient Transfections
For chromosome visualization, cells were treated with CellLight Histone H2B-
RFP, BacMam 2.0 (Life Technologies) overnight. For reintroduction of MPS1,
cells were transfected the day prior to live-cell imaging with TFP-MPS1 using
Fugene 6. Transfection medium was removed and changed to L-15 medium
on the day of filming.
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